Neogene Therapeutics is a pre-clinical stage biotechnology company aiming to change the paradigm of treatment for solid cancers. Our mission is to provide cancer patients with T cell therapies targeting mutated proteins called neo-antigens, which are present on cancer cells as a consequence of DNA mutations. Neogene is developing novel technologies to enable the engineering of ‘designer T cells’ with neo-antigen specificities that display an optimized ability to seek and destroy cancer cells.
We are seeking a highly motivated individual with experience in molecular biology and next generation sequencing (NGS) technologies to join our personalized TCR discovery team in Amsterdam as a (Senior) Research Associate. The personalized TCR discovery team is responsible for isolating neo-antigen specific TCRs from a cancer patient’s tumor biopsy & characterizing these tumor derived TCRs. Following isolation and characterization, neo-antigen specific TCRs are selected for the clinical manufacture of a fully personalized multi-specificity neo-antigen specific TCR engineered T cell therapy product that is used to treat the cancer patient. Reporting to a Senior Scientist in the personalized TCR discovery team, the individual will assume responsibility for performing experiments to isolate patient-derived neo-antigen specific TCRs for clinical use.
Responsibilities include, but are not limited to:
We offer the opportunity to join a highly dynamic biotech start-up. You can expect a collaborative environment created by a team with deep scientific expertise and an industrial track-record in T cell therapies. We value pro-active team-players who pursue their goals with dedication, endurance and a daring mindset. If you share our commitment to make a difference to patients in need, we can provide an exciting opportunity for your career.
If you are interested please submit your electronic application including cover letter and CV to email@example.com
No recruiters. No phone calls.